Skip to main content

Abstract

Ocular inflammation is known to be accompanied by retinal cell impairment. In uveitis, there are numerous causes of the retinal cell damage. However, secondary intraocular hypertension and direct inflammation caused by the uveitis are major concerns, as both of these can affect retinal cell survival. This is especially the case in sarcoidosis and Vogt–Koyanagi–Harada disease, which are the most common types of uveitis seen clinically in Japan. In addition, Behçet’s disease and acute retinal necrosis are also known to have a poor prognosis when patients are unable to receive precise treatments at specific time points during the clinical progress of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ohguro N, Sonoda KH, Takeuchi M, Matsumura M, Mochizuki M (2012) The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol 56:432–435

    Article  PubMed  Google Scholar 

  2. Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224–1234

    Article  CAS  PubMed  Google Scholar 

  3. Hunninghake GW, Crystal RG (1981) Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 305:429–434

    Article  CAS  PubMed  Google Scholar 

  4. (1999) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160: 736–755 http://www.ncbi.nlm.nih.gov/pubmed/?term=Joint+Statement+of+the+American+Thoracic+Society+(ATS)%2C

  5. Hiraga Y (1994) An epidemiological study of clustering of sarcoidosis cases. Nippon Rinsho 52:1438–1442

    CAS  PubMed  Google Scholar 

  6. Hosoda Y, Hiraga Y, Odaka M et al (1976) A cooperative study of sarcoidosis in Asia and Africa: analytic epidemiology. Ann N Y Acad Sci 278:355–367

    Article  CAS  PubMed  Google Scholar 

  7. Ishige I, Usui Y, Takemura T, Eishi Y (1999) Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 354:120–123

    Article  CAS  PubMed  Google Scholar 

  8. McGrath DS, Goh N, Foley PJ, du Bois RM (2001) Sarcoidosis: genes and microbes–soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 18:149–164

    CAS  PubMed  Google Scholar 

  9. Lynch JP 3rd, Sharma OP, Baughman RP (1998) Extrapulmonary sarcoidosis. Semin Respir Infect 13:229–254

    PubMed  Google Scholar 

  10. Crick RP, Hoyle C, Smellie H (1961) The Eyes in Sarcoidosis. Br J Ophthalmol 45:461–481

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Ohara K, Okubo A, Sasaki H, Kamata K (1992) Intraocular manifestations of systemic sarcoidosis. Jpn J Ophthalmol 36:452–457

    CAS  PubMed  Google Scholar 

  12. Jabs DA, Johns CJ (1986) Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 102:297–301

    CAS  PubMed  Google Scholar 

  13. Bonfioli AA, Orefice F (2005) Sarcoidosis. Semin Ophthalmol 20:177–182

    Article  PubMed  Google Scholar 

  14. Costabel U, Zaiss AW, Guzman J (1992) Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 9(Suppl 1):211–214

    Google Scholar 

  15. Kojima K, Maruyama K, Inaba T et al (2012) The CD4/CD8 ratio in vitreous fluid is of high diagnostic value in sarcoidosis. Ophthalmology 119:2386–2392

    Article  PubMed  Google Scholar 

  16. Siltzbach LE, James DG, Neville E et al (1974) Course and prognosis of sarcoidosis around the world. Am J Med 57:847–852

    Article  CAS  PubMed  Google Scholar 

  17. Palestine AG, Nussenblatt RB, Chan CC (1986) Treatment of intraocular complications of sarcoidosis. Ann N Y Acad Sci 465:564–574

    Article  CAS  PubMed  Google Scholar 

  18. Nagata K, Maruyama K, Uno K et al (2012) Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis. Invest Ophthalmol Vis Sci 53:3827–3833

    Article  CAS  PubMed  Google Scholar 

  19. Forster DJ, Rao NA, Hill RA, Nguyen QH, Baerveldt G (1993) Incidence and management of glaucoma in Vogt-Koyanagi-Harada syndrome. Ophthalmology 100:613–618

    Article  CAS  PubMed  Google Scholar 

  20. Nowilaty SR, Bouhaimed M (2006) Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 90:982–986

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Keino H, Goto H, Usui M (2002) Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation. Graefes Arch Clin Exp Ophthalmol 240:878–882

    Article  PubMed  Google Scholar 

  22. Mullaney J, Collum LM (1985) Ocular vasculitis in Behcet’s disease. A pathological and immunohistochemical study. Int Ophthalmol 7:183–191

    Article  CAS  PubMed  Google Scholar 

  23. Ahn JK, Yu HG, Chung H, Park YG (2006) Intraocular cytokine environment in active Behcet uveitis. Am J Ophthalmol 142:429–434

    Article  CAS  PubMed  Google Scholar 

  24. Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G (1989) Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet’s disease. Lancet 1:1093–1096

    Article  CAS  PubMed  Google Scholar 

  25. Yazici H, Pazarli H, Barnes CG et al (1990) A controlled trial of azathioprine in Behcet’s syndrome. N Engl J Med 322:281–285

    Article  CAS  PubMed  Google Scholar 

  26. Whitcup SM, Salvo EC Jr, Nussenblatt RB (1994) Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behcet’s disease. Am J Ophthalmol 118:39–45

    CAS  PubMed  Google Scholar 

  27. Okada AA, Goto H, Ohno S, Mochizuki M (2012) Multicenter study of infliximab for refractory uveoretinitis in Behcet disease. Arch Ophthalmol 130:592–598

    Article  CAS  PubMed  Google Scholar 

  28. Topilow HW, Nussbaum JJ, Freeman HM, Dickersin GR, Szyfelbein W (1982) Bilateral acute retinal necrosis. Clinical and ultrastructural study. Arch Ophthalmol 100:1901–1908

    Article  CAS  PubMed  Google Scholar 

  29. Culbertson WW, Blumenkranz MS, Haines H, Gass DM, Mitchell KB, Norton EW (1982) The acute retinal necrosis syndrome. Part 2: Histopathology and etiology. Ophthalmology 89:1317–1325

    Article  CAS  PubMed  Google Scholar 

  30. Ganatra JB, Chandler D, Santos C, Kuppermann B, Margolis TP (2000) Viral causes of the acute retinal necrosis syndrome. Am J Ophthalmol 129:166–172

    Article  CAS  PubMed  Google Scholar 

  31. Sugita S, Iwanaga Y, Kawaguchi T et al (2008) Detection of herpesvirus genome by multiplex polymerase chain reaction (PCR) and real-time PCR in ocular fluids of patients with acute retinal necrosis. Nihon Ganka Gakkai Zasshi 112:30–38

    CAS  PubMed  Google Scholar 

  32. Sugita S, Shimizu N, Watanabe K et al (2008) Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis. Br J Ophthalmol 92:928–932

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Holland GN (1994) Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol 117:663–667

    CAS  PubMed  Google Scholar 

  34. Tawara A, Tou N, Kubota T, Harada Y, Yokota K (2008) Immunohistochemical evaluation of the extracellular matrix in trabecular meshwork in steroid-induced glaucoma. Graefes Arch Clin Exp Ophthalmol 246:1021–1028

    Article  CAS  PubMed  Google Scholar 

  35. Takahashi T, Ohtani S, Miyata K, Miyata N, Shirato S, Mochizuki M (2002) A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol 46:556–562

    Article  PubMed  Google Scholar 

  36. Miserocchi E, Waheed NK, Dios E et al (2002) Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. Ophthalmology 109:1532–1537

    Article  PubMed  Google Scholar 

  37. Zhang X, Clark AF, Yorio T (2008) FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness. Invest Ophthalmol Vis Sci 49:1037–1047

    Article  PubMed Central  PubMed  Google Scholar 

  38. Steely HT, Browder SL, Julian MB, Miggans ST, Wilson KL, Clark AF (1992) The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci 33:2242–2250

    CAS  PubMed  Google Scholar 

  39. Benedikt O, Roll P (1979) The trabecular meshwork of a non-glaucomatous eye with the exfoliation syndrome. Electronmicroscopic study. Virchows Arch A Pathol Anat Histol 384:347–355

    Article  CAS  PubMed  Google Scholar 

  40. Rohen JW, Linner E, Witmer R (1973) Electron microscopic studies on the trabecular meshwork in two cases of corticosteroid-glaucoma. Exp Eye Res 17:19–31

    Article  CAS  PubMed  Google Scholar 

  41. Roll P, Benedikt O (1979) Electronmicroscopic studies of the trabecular meshwork in corticosteroid glaucoma. Klin Monbl Augenheilkd 174:421–428

    CAS  PubMed  Google Scholar 

  42. van Boxtel LA, van der Lelij A, van der Meer J, Los LI (2007) Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology 114:1358–1362

    Article  PubMed  Google Scholar 

  43. Kass MA, Becker B, Kolker AE (1973) Glaucomatocyclitic crisis and primary open-angle glaucoma. Am J Ophthalmol 75:668–673

    CAS  PubMed  Google Scholar 

  44. Jap A, Sivakumar M, Chee SP (2001) Is Posner Schlossman syndrome benign? Ophthalmology 108:913–918

    Article  CAS  PubMed  Google Scholar 

  45. Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH (2008) Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol 145:834–840

    Article  PubMed  Google Scholar 

  46. Dinakaran S, Kayarkar V (2002) Trabeculectomy in the management of Posner-Schlossman syndrome. Ophthalmic Surg Lasers 33:321–322

    PubMed  Google Scholar 

  47. Nakazawa T, Kayama M, Ryu M et al (2011) Tumor necrosis factor-alpha mediates photoreceptor death in a rodent model of retinal detachment. Invest Ophthalmol Vis Sci 52:1384–1391

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kazuichi Maruyama M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Japan

About this chapter

Cite this chapter

Maruyama, K. (2014). Neuroinflammation. In: Nakazawa, T., Kitaoka, Y., Harada, T. (eds) Neuroprotection and Neuroregeneration for Retinal Diseases. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54965-9_20

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54965-9_20

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54964-2

  • Online ISBN: 978-4-431-54965-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics